Interleukin-1 beta induction of neuron apoptosis depends on p38 mitogen-activated protein kinase activity after spinal cord injury

Acta Pharmacol Sin. 2005 Aug;26(8):934-42. doi: 10.1111/j.1745-7254.2005.00152.x.

Abstract

Aim: Interleukin-1 beta (IL-1beta) has been implicated as an extracellular signal in the initiation of apoptosis in neurons and oligodendrocytes after spinal cord injury (SCI). To further characterize the apoptotic cascade initiated by IL-1beta after SCI, we examined the expression of IL-1beta, p38 mitogen-activated protein kinase (p38 MAPK) and caspase-3 after SCI, and further investigated whether p38 MAPK was involved in neuron apoptosis induced by IL-1beta.

Methods: Adult rats were given contusion SCI at the T-10 vertebrae level with a weight-drop impactor (10 g weight dropped 25.0 mm). The expression levels of IL-1beta, p38 MAPK and caspase-3 after SCI were assessed with Western blots, immunohistochemistry staining, and real time reverse transcription polymerase chain reactions (RT-PCR). Neuron apoptosis was assessed with the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL) method.

Results: Increased levels of IL-1beta and p38 MAPK were observed soon after injury, with a peak in expression levels within 6 h of injury. By 24 h after injury, caspase-3 expression was markedly increased in the injured spinal cord. TUNEL-positive cells were first observed in the lesioned area 6 h after SCI. The largest number of TUNEL-positive cells was observed at 24 h post-SCI. Intrathecal injection of the IL-1 receptor antagonist IL-1Ra significantly reduced expression of p38 MAPK and caspase-3, and reduced the number of TUNEL-positive cells. Moreover, intrathecal injection of an inhibitor of p38 MAPK, SB203580, also significantly reduced the expression of caspase-3, and reduced the number of TUNEL-positive cells in the injured spinal cord.

Conclusion: The p38MAPK signaling pathway plays an important role in IL-1beta mediated induction of neuron apoptosis following SCI in rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Blotting, Western
  • Caspase 3
  • Caspase Inhibitors
  • Caspases / genetics
  • Caspases / metabolism
  • Enzyme Activation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Gene Expression / drug effects
  • Imidazoles / pharmacology
  • Immunohistochemistry
  • In Situ Nick-End Labeling
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1 / genetics
  • Interleukin-1 / metabolism*
  • Male
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Pyridines / pharmacology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Receptors, Interleukin-1 / antagonists & inhibitors
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sialoglycoproteins / pharmacology
  • Spinal Cord Injuries / physiopathology*
  • Time Factors
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • p38 Mitogen-Activated Protein Kinases / genetics
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • Caspase Inhibitors
  • Enzyme Inhibitors
  • Imidazoles
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1
  • Pyridines
  • RNA, Messenger
  • Receptors, Interleukin-1
  • Sialoglycoproteins
  • p38 Mitogen-Activated Protein Kinases
  • Casp3 protein, rat
  • Caspase 3
  • Caspases
  • SB 203580